Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6

FEBS Letters

Volumn 586, Issue 6, 2012, Pages 866-874

  Cai, Yi ^a   Yu, Shan Shan ^b   Chen, Shao Rui ^a   Pi, Rong Biao ^a   Gao, Si ^a   Li, Hong ^a   Ye, Jian Tao ^a   Liu, Pei Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Ang II; Cardiac hypertrophy; NAD; Nmnat2; Sirtuin 6

Indexed keywords

ANGIOTENSIN II; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE 2; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; SIRTUIN 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ENLARGEMENT; CELL LEVEL; DOWN REGULATION; ENZYME ACTIVITY; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; MALE; MUTANT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMIDE SYNTHASES; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; GENE KNOCKDOWN TECHNIQUES; ISOENZYMES; MALE; MYOCYTES, CARDIAC; NAD; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SIRTUINS; TISSUE DISTRIBUTION;

RATTUS;

EID: 84862786955     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.02.014     Document Type: Article

References (36)

1. Michan, S. and Sinclair, D. (2007) Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. (Pubitemid 46788079)
2. Sauve, A.A., Wolberger, C., Schramm, V.L. and Boeke, J.D. (2006) The biochemistry of sirtuins. Annu. Rev. Biochem. 75, 435-465. (Pubitemid 44118039)
3. Planavila, A., Iglesias, R., Giralt, M. and Villarroya, F. (2011) Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res. 90, 276-284.
4. Sundaresan, N.R., Gupta, M., Kim, G., Rajamohan, S.B., Isbatan, A. and Gupta, M.P. (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119, 2758-2771.
5. Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T. and Bober, E. (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 102, 703-710. (Pubitemid 351457857)
6. Lin, S.J. and Guarente, L. (2003) Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr. Opin. Cell Biol. 15, 241-246.
7. Imai, S., Armstrong, C.M., Kaeberlein, M. and Guarente, L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800. (Pubitemid 30111843)
8. Borradaile, N.M. and Pickering, J.G. (2009) NAD(+), sirtuins, and cardiovascular disease. Curr. Pharm. Des. 15, 110-117.
9. Pillai, V.B. et al. (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 285, 3133-3144.
10. Rongvaux, A., Andris, F., Van Gool, F. and Leo, O. (2003) Reconstructing eukaryotic NAD metabolism. BioEssays 25, 683-690. (Pubitemid 36850796)
11. Pillai, J.B., Isbatan, A., Imai, S. and Gupta, M.P. (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. 280, 43121-43130. (Pubitemid 43049278)
12. Hsu, C.P., Oka, S., Shao, D., Hariharan, N. and Sadoshima, J. (2009) Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ. Res. 105, 481-491.
13. Lau, C., Niere, M. and Ziegler, M. (2009) The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front. Biosci. 14, 410-431.
14. Berger, F., Lau, C., Dahlmann, M. and Ziegler,M. (2005) Subcellular compartmentation and differential catalytic properties of the threehuman nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280, 36334-36341. (Pubitemid 41633907)
15. Phrommintikul, A., Tran, L., Kompa, A., Wang, B., Adrahtas, A., Cantwell, D., Kelly, D.J. and Krum, H. (2008) Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 294, H1804-H1814. (Pubitemid 351490610)
16. Li, R., Zheng, W., Pi, R., Gao, J., Zhang, H., Wang, P., Le, K. and Liu, P. (2007) Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy. FEBS Lett. 581, 3311-3316. (Pubitemid 46977373)
17. Wollert, K.C. and Drexler, H. (1999) The renin-angiotensin system and experimental heart failure. Cardiovasc. Res. 43, 838-849. (Pubitemid 29413183)
18. Canto, C. et al. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
19. Zima, A.V., Copello, J.A. and Blatter, L.A. (2004) Effects of cytosolic NADH/ NAD(+) levels on sarcoplasmic reticulum Ca(2+) release in permeabilized rat ventricular myocytes. J. Physiol. 555, 727-741. (Pubitemid 38404593)
20. Revollo, J.R. et al. (2007) Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363-375. (Pubitemid 350011996)
21. Hayashida, S., Arimoto, A., Kuramoto, Y., Kozako, T., Honda, S., Shimeno, H. and Soeda, S. (2010) Fasting promotes the expression of SIRT1, an NAD+- dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem. 339, 285-292.
22. Polito, L., Kehoe, P.G., Forloni, G. and Albani, D. (2010) The molecular genetics of sirtuins: association with human longevity and age-related diseases. Int. J. Mol. Epidemiol. Genet. 1, 214-225.
23. Hsu, C.P., Odewale, I., Alcendor, R.R. and Sadoshima, J. (2008) Sirt1 protects the heart from aging and stress. Biol. Chem. 389, 221-231. (Pubitemid 351329030)
24. Zheng, T. and Lu, Y. (2011) Changes in SIRT1 expression and its downstream pathways in age-related cataract in humans. Curr. Eye Res. 36, 449-455.
25. Zhang, C. et al. (2011) Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovasc. Res. 90, 538-545.
26. Alcendor, R.R. et al. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521. (Pubitemid 46834764)
27. Schwartz, A.L. and Ciechanover, A. (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50, 57-74. (Pubitemid 29117052)
28. Predmore, J.M. et al. (2010) Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121, 997-1004.
29. Lecker, S.H., Goldberg, A.L. and Mitch, W.E. (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17, 1807-1819. (Pubitemid 44036165)
30. Depre, C. et al. (2006) Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 114, 1821-1828. (Pubitemid 44673357)
31. Kanfi, Y. et al. (2008) Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett. 582, 543-548.
32. Gilley, J. and Coleman, M.P. (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 8, e1000300.
33. Lareau, L.F., Inada, M., Green, R.E., Wengrod, J.C. and Brenner, S.E. (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446, 926-929. (Pubitemid 46633161)
34. Ni, J.Z. et al. (2007) Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 21, 708-718. (Pubitemid 46440292)
35. Wollerton, M.C., Gooding, C., Wagner, E.J., Garcia-Blanco, M.A. and Smith, C.W. (2004) Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13, 91-100. (Pubitemid 38117118)
36. Vidakovic, M., Gluch, A., Qiao, J., Oumard, A., Frisch, M., Poznanovic, G. and Bode, J. (2009) PARP-1 expression in the mouse is controlled by an autoregulatory loop: PARP-1 binding to an upstream S/MAR element and to a novel recognition motif in its promoter suppresses transcription. J. Mol. Biol. 388, 730-750.